KIO-104 — Initial data
in late 2026
We expect to report initial clinical data in late 2026.Source filing
KPRX biotech catalysts & pipeline
KIORA PHARMACEUTICALS INC · Data as of 2026-09-08
Upcoming catalysts
KIO-104 — Topline data
H1 2027
These milestones meaningfully advanced our goal of delivering new treatment options for patients with retinal diseases and position us for anticipated clinical data in the first half of 2027.Source filing
KIO-301 — Topline data
Q3 2027
We expect the last patient, first visit in the first quarter of 2027 with topline data in the third quarter of 2027.Source filing